AGIO
Agios Pharmaceuticals, Inc.
stockNASDAQ
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 30.97 | 2026-10-14 | +20.05% | 7.177 |
| 1M | 33.95 | 2026-09-21 | +9.51% | 0.925 |
| 3M | 37.36 | 2026-07-21 | -0.48% | 0.243 |
| 6M | 26.29 | 2026-04-21 | +41.42% | -0.044 |
| 1Y | 43.45 | 2025-10-21 | -14.43% | 0.474 |
| 2Y | 45.66 | 2024-10-21 | -18.57% | — |
| 5Y | 47.99 | 2021-10-21 | -22.53% | 1.190 |
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) stock price today is $37.18, and today's volume is 631,287. AGIO is up 1.474% today. The 30 day average volume is 1.17M. AGIO market cap is $2.22B with 59.70M shares outstanding.